Hbk Sorce Advisory LLC Edwards Lifesciences Corp Transaction History

Hbk Sorce Advisory LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$84.3 - $94.31 $10,368 - $11,600	-123 Reduced 1.4%	8,638 $797,000
Q1 2024 May 09, 2024	SELL	$72.54 - $95.56 $62,602 - $82,468	-863 Reduced 8.97%	8,761 $837,000
Q4 2023 Jan 25, 2024	BUY	$61.71 - $77.76 $6,911 - $8,709	112 Added 1.18%	9,624 $733,000
Q3 2023 Nov 06, 2023	SELL	$69.28 - $93.38 $554 - $747	-8 Reduced 0.08%	9,512 $658,000
Q2 2023 Aug 04, 2023	SELL	$81.41 - $94.33 $803,679 - $931,225	-9,872 Reduced 50.91%	9,520 $898,000
Q1 2023 Aug 15, 2023	BUY	$74.26 - $84.51 $891 - $1,014	12 Added 0.13%	9,532 $788,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $1.44 Million - $1.64 Million	19,392 New	19,392 $2.41 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $174,235 - $222,303	-4,685 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$33.79 - $39.39 $158,306 - $184,542	4,685	4,685 $528,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.